Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

Structural cortical network reorganization associated with early conversion to multiple sclerosis.

Tur C, Eshaghi A, Altmann DR, Jenkins TM, Prados F, Grussu F, Charalambous T, Schmidt A, Ourselin S, Clayden JD, Wheeler-Kingshott CAMG, Thompson AJ, Ciccarelli O, Toosy AT.

Sci Rep. 2018 Jul 16;8(1):10715. doi: 10.1038/s41598-018-29017-1.

2.

Deep gray matter volume loss drives disability worsening in multiple sclerosis.

Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group.

Ann Neurol. 2018 Feb;83(2):210-222. doi: 10.1002/ana.25145. Epub 2018 Feb 6.

3.

Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis.

Afolabi D, Albor C, Zalewski L, Altmann DR, Baker D, Schmierer K.

Mult Scler. 2018 Oct;24(11):1461-1468. doi: 10.1177/1352458517726380. Epub 2017 Aug 17.

4.

Neuronal loss, demyelination and volume change in the multiple sclerosis neocortex.

Carassiti D, Altmann DR, Petrova N, Pakkenberg B, Scaravilli F, Schmierer K.

Neuropathol Appl Neurobiol. 2018 Jun;44(4):377-390. doi: 10.1111/nan.12405. Epub 2017 Jun 1.

5.

FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?

Campion T, Smith RJP, Altmann DR, Brito GC, Turner BP, Evanson J, George IC, Sati P, Reich DS, Miquel ME, Schmierer K.

Eur Radiol. 2017 Oct;27(10):4257-4263. doi: 10.1007/s00330-017-4822-z. Epub 2017 Apr 13.

6.

Axonal loss in the multiple sclerosis spinal cord revisited.

Petrova N, Carassiti D, Altmann DR, Baker D, Schmierer K.

Brain Pathol. 2018 May;28(3):334-348. doi: 10.1111/bpa.12516. Epub 2017 May 7.

7.

Reduced Field-of-View Diffusion-Weighted Imaging of the Lumbosacral Enlargement: A Pilot In Vivo Study of the Healthy Spinal Cord at 3T.

Yiannakas MC, Grussu F, Louka P, Prados F, Samson RS, Battiston M, Altmann DR, Ourselin S, Miller DH, Gandini Wheeler-Kingshott CA.

PLoS One. 2016 Oct 14;11(10):e0164890. doi: 10.1371/journal.pone.0164890. eCollection 2016.

8.

Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes.

Brownlee WJ, Miszkiel KA, Altmann DR, Ciccarelli O, Miller DH.

Mult Scler. 2017 Jun;23(7):1031-1034. doi: 10.1177/1352458516667565. Epub 2016 Sep 6.

9.

Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome.

Brownlee WJ, Altmann DR, Alves Da Mota P, Swanton JK, Miszkiel KA, Wheeler-Kingshott CG, Ciccarelli O, Miller DH.

Mult Scler. 2017 Apr;23(5):665-674. doi: 10.1177/1352458516663034. Epub 2016 Aug 6.

10.

Phenytoin for neuroprotection - Authors' reply.

Kapoor R, Raftopoulos R, Altmann DR, Miller DH, Hickman SJ.

Lancet Neurol. 2016 Aug;15(9):902-903. doi: 10.1016/S1474-4422(16)30094-1. No abstract available.

PMID:
27478948
11.

Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.

Tur C, Goodkin O, Altmann DR, Jenkins TM, Miszkiel K, Mirigliani A, Fini C, Gandini Wheeler-Kingshott CA, Thompson AJ, Ciccarelli O, Toosy AT.

Brain. 2016 Mar;139(Pt 3):816-28. doi: 10.1093/brain/awv396. Epub 2016 Feb 17.

12.

Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.

Raftopoulos R, Hickman SJ, Toosy A, Sharrack B, Mallik S, Paling D, Altmann DR, Yiannakas MC, Malladi P, Sheridan R, Sarrigiannis PG, Hoggard N, Koltzenburg M, Gandini Wheeler-Kingshott CA, Schmierer K, Giovannoni G, Miller DH, Kapoor R.

Lancet Neurol. 2016 Mar;15(3):259-69. doi: 10.1016/S1474-4422(16)00004-1. Epub 2016 Jan 26.

PMID:
26822749
13.

Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis.

Yiannakas MC, Mustafa AM, De Leener B, Kearney H, Tur C, Altmann DR, De Angelis F, Plantone D, Ciccarelli O, Miller DH, Cohen-Adad J, Gandini Wheeler-Kingshott CA.

Neuroimage Clin. 2015 Nov 10;10:71-7. doi: 10.1016/j.nicl.2015.11.001. eCollection 2016.

14.

White and gray matter damage in primary progressive MS: The chicken or the egg?

Bodini B, Chard D, Altmann DR, Tozer D, Miller DH, Thompson AJ, Wheeler-Kingshott C, Ciccarelli O.

Neurology. 2016 Jan 12;86(2):170-6. doi: 10.1212/WNL.0000000000002237. Epub 2015 Dec 16.

15.

No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.

Pakpoor J, Disanto G, Altmann DR, Pavitt S, Turner BP, Marta M, Juliusson G, Baker D, Chataway J, Schmierer K.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 1;2(6):e158. doi: 10.1212/NXI.0000000000000158. eCollection 2015 Dec.

16.

Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.

Kearney H, Miszkiel KA, Yiannakas MC, Altmann DR, Ciccarelli O, Miller DH.

Mult Scler. 2016 Jun;22(7):910-20. doi: 10.1177/1352458515604905. Epub 2015 Oct 2.

PMID:
26432854
17.

Motor network efficiency and disability in multiple sclerosis.

Pardini M, Yaldizli Ö, Sethi V, Muhlert N, Liu Z, Samson RS, Altmann DR, Ron MA, Wheeler-Kingshott CA, Miller DH, Chard DT.

Neurology. 2015 Sep 29;85(13):1115-22. doi: 10.1212/WNL.0000000000001970. Epub 2015 Aug 28.

18.

Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis.

Altmann DR, Button T, Schmierer K, Hunter K, Tozer DJ, Wheeler-Kingshott CA, Coles A, Miller DH.

Mult Scler Relat Disord. 2014 Mar;3(2):237-43. doi: 10.1016/j.msard.2013.09.007. Epub 2013 Oct 9.

PMID:
25878011
19.

Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.

Abdel-Aziz K, Schneider T, Solanky BS, Yiannakas MC, Altmann DR, Wheeler-Kingshott CA, Peters AL, Day BL, Thompson AJ, Ciccarelli O.

Brain. 2015 Jun;138(Pt 6):1568-82. doi: 10.1093/brain/awv086. Epub 2015 Apr 10.

20.

Cervical cord lesion load is associated with disability independently from atrophy in MS.

Kearney H, Altmann DR, Samson RS, Yiannakas MC, Wheeler-Kingshott CA, Ciccarelli O, Miller DH.

Neurology. 2015 Jan 27;84(4):367-73. doi: 10.1212/WNL.0000000000001186. Epub 2014 Dec 24.

PMID:
25540312

Supplemental Content

Loading ...
Support Center